Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Classificação em ações #28131
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Preço da ação
$0.37430781
Última sincronização: 2026-08-19
Valor de mercado
$28.37M
Variação (1 dia)
2.00%
Variação (1 ano)
-13.46%
País
CA
Negociar Defence Therapeutics Inc. (DTC)

Categoria

Preço DTC com a capitalização de mercado de B
Defence Therapeutics Inc. Defence Therapeutics Inc.
DTC
$0.37430781
Capitalização de mercado de Defence Therapeutics Inc.(DTC)
Valor de mercado: $28.37M
Em August 2026, Defence Therapeutics Inc. tem uma capitalização de mercado de $28.37M. Isso faz com que Defence Therapeutics Inc. seja a 28131st empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Defence Therapeutics Inc. de 2021 a 2026
DTC comparado com o topo de 5 mais populares stocks
Preço para DTC Ativo B Capitalização de mercado de B Resultados
Defence Therapeutics Inc. Defence Therapeutics Inc.
$69,938.64 $28.37M
$5.301T +18,684,692.99%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$61,138.37 $28.37M
$4.634T +16,333,614.82%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$54,661.70 $28.37M
$4.143T +14,603,308.09%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$47,357.50 $28.37M
$3.589T +12,651,919.85%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$37,694.03 $28.37M
$2.857T +10,070,230.74%